AI to Accelerate Diagnosis of Retinal Disorders

New-Stem-Cell-Treatment-Can-Cure-Macular-Degeneration

Artificial Intelligence-based neural network reviews more than 200,000 eye scans with optical coherence tomography to create two- and three-dimensional representations of retinal tissue

The findings of the study was published on February 22, 2018 in journal of Cell. Researchers from Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas developed new software for detection of retinal disorders for speeding up diagnosis and treatment. The study was focused macular degeneration and diabetic macular edema, which are two major causes of blindness. This machine learning technique was found to be as accurate as trained ophthalmologist. It generates most referred treatment to the patients within 30 seconds with 95% accuracy.

Conventional approaches to diagnose retinal disorders are laborious and expensive. They require millions of images to program AI system. In this study, researchers used AI-based convolutional neural network, which was capable of reviewing more than 200,000 eye scans with optical coherence tomography. It is a noninvasive technology, which transmits light to retina to creating two- and three-dimensional representations of tissue.

“Artificial intelligence (AI) has huge potential to revolutionize disease diagnosis and management by doing analyses and classifications involving immense amounts of data that are difficult for human experts—and doing them rapidly,” said senior author Kang Zhang, MD, PhD, professor of ophthalmology at Shiley Eye Institute and founding director of the Institute for Genomic Medicine at UC San Diego School of Medicine.

Speed and accuracy are the most important steps in medical diagnoses and treatment. Simple and relatively inexpensive AI-based tool could help various medical resources and specialists in efficient treatment of disorders. Furthermore, AI technology can also differentiate between benign and malignant lesions in just one scan. The scientists are sharing data their data through open-source so that other research organizations can develop potential applications.

You may be interested

Mobile Health Apps and Solutions Market Industry Insights, Dynamic Growth and Revenue Forecast 2018-2026
Business
Business

Mobile Health Apps and Solutions Market Industry Insights, Dynamic Growth and Revenue Forecast 2018-2026

Albert R - October 19, 2018

Mobile Health Apps and Solutions Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of…

Drug Abuse Treatment Market – Launch and approval of novel drugs is projected to fuel market growth over the forecast period
Business
Business

Drug Abuse Treatment Market – Launch and approval of novel drugs is projected to fuel market growth over the forecast period

Mohit Joshi - October 19, 2018

Coherent Market Insights released a new market study on 2018-2026 Drug Abuse Treatment Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages…

Elderly and Disabled Assistive Devices Market in the US Market: Business Opportunities, Current Trends, Market Challenges & Industry Analysis By 2026
Business
Business

Elderly and Disabled Assistive Devices Market in the US Market: Business Opportunities, Current Trends, Market Challenges & Industry Analysis By 2026

Albert R - October 19, 2018

The Elderly and Disabled Assistive Devices Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently…

Most from this category